GLOBAL LONGLIFE HOSPITAL AND RESEARCH LIMITED Global Longlife Hospital and Research Limited Stock
Equities
543520
INE0J2K01014
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.38 INR | -1.59% |
|
+1.92% | -3.20% |
| Sales 2022 | 328M 3.93M | Sales 2023 | 235M 2.82M | Capitalization | 470M 5.64M |
|---|---|---|---|---|---|
| Net income 2022 | 35M 420K | Net income 2023 | 18M 216K | EV / Sales 2022 * | - |
| Net Debt 2022 | 83.74M 1M | Net Debt 2023 | 55.73M 668K | EV / Sales 2023 | 2.24 x |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
25
x | Employees | 103 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 18.99% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.59% | ||
| 1 week | +1.92% | ||
| Current month | +1.05% | ||
| 1 month | -0.53% | ||
| 3 months | -20.42% | ||
| 6 months | -5.70% | ||
| Current year | -3.20% |
1 week
38.00
44.38
1 month
38.0044.38
Current year
38.0061.70
1 year
36.2561.70
3 years
36.25141.10
5 years
36.25141.10
10 years
36.25141.10
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 35 | 15-07-04 | |
| Director of Finance/CFO | - | 16-02-29 | |
Tanvi Solanki
CMP | Compliance Officer | - | Oct. 31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 44 | 21-08-05 | |
| Director/Board Member | 32 | 21-08-01 | |
| Director/Board Member | 31 | 21-08-01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-03 | 41.38 | -1.59% | 2,000 |
| 24-05-02 | 42.05 | +2.69% | 27,000 |
| 24-04-30 | 40.95 | +0.99% | 1,000 |
| 24-04-29 | 40.55 | -0.12% | 1,000 |
Delayed Quote Bombay S.E., May 03, 2024 at 06:00 am EDT
More quotes
Global Longlife Hospital and Research Limited is a multispecialty hospital operator providing medical and allied services. The Company offers medical services across oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, gi medicine, gynecology, infectious disease, nephrology and neurology. Its surgical services include cvts, joint replacement and ortho, general surgery, onco surgery, gi surgery, neurosurgery and ear, nose and throat. Its radiology services include mammography, ct scan, x-ray, ultrasound, endoscopy, sonography, and others. Its pathology services include microbiology, biochemistry, clinical pathology, cyto pathology, hematology, serology, and others. Its other services include dialysis, pharmacy, ambulance, dietary and physiotherapy.
Calendar
2024-05-27
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -3.20% | 5.21M | |
| -18.46% | 16.57B | |
| +4.50% | 12.51B | |
| +4.31% | 11.69B | |
| +5.36% | 10.36B | |
| +24.72% | 8.38B | |
| -2.64% | 7.75B | |
| +20.04% | 7.16B | |
| +4.17% | 6.6B | |
| +46.90% | 4.54B |
- Stock Market
- Equities
- 543520 Stock
